Evidence map›Paper›PMID 30871351›Full record

ArticleCirculation. Heart failure2019

Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy.

Victoria N Parikh, Colleen Caleshu, Chloe Reuter, Laura C Lazzeroni, Jodie Ingles, John Garcia, Kristen McCaleb, Tolulope Adesiyun, Farbod Sedaghat-Hamedani, Saurabh Kumar and 20 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation. Heart failure, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 1 pooled it
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 1 synthesis or guideline pooled it, 143 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Early Onset Heart Failure due toClinical case reports · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Deciphering epistatic genetic regulation of cardiac hypertrophy.medRxiv : the preprint server for health sciences · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 12 institutions in 5 countries.

Victoria N ParikhDivision of Cardiovascular Medicine, Department of Medicine (V.N.P., C.C., C.R., M.T.W., E.A.A.), Stanford University School of Medicine, CA.
Colleen CaleshuDivision of Cardiovascular Medicine, Department of Medicine (V.N.P., C.C., C.R., M.T.W., E.A.A.), Stanford University School of Medicine, CA.
Chloe ReuterDivision of Cardiovascular Medicine, Department of Medicine (V.N.P., C.C., C.R., M.T.W., E.A.A.), Stanford University School of Medicine, CA.
Laura C LazzeroniDepartment of Psychiatry and Behavioral Sciences (L.C.L.), Stanford University School of Medicine, CA.
Jodie InglesDepartment of Cardiology, Royal Prince Alfred Hospital and Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, University of Sydney, New South Wales, Australia (J.I., C.S.).
John GarciaInvitae, Inc, San Francisco, CA (J.G., R.N.).
Kristen McCalebGenomic Health, Inc, Redwood City, CA (K.M.).
Tolulope AdesiyunJohns Hopkins School of Medicine, Baltimore, MD (T.A.).
Farbod Sedaghat-HamedaniInstitute for Cardiomyopathies, University Hospital Heidelberg, German Center for Cardiovascular Research (F.S.-H., B.M.).
Saurabh KumarBrigham and Women's Hospital, Partners Health Care and Harvard Medical School, Boston, MA (S.K., N.K.L.).
Sharon GrawCardiovascular Institute, University of Colorado Anschutz Medical Campus, Aurora (S.G., M.R.G.T., L.M.).
Marta GigliCardiovascular Department, Azienda Sanitaria Universitaria Integrata, University of Trieste, Italy (M.G., D.S., M.D.F., M.M., G.S.).
Davide StolfoCardiovascular Department, Azienda Sanitaria Universitaria Integrata, University of Trieste, Italy (M.G., D.S., M.D.F., M.M., G.S.).
Matteo Dal FerroCardiovascular Department, Azienda Sanitaria Universitaria Integrata, University of Trieste, Italy (M.G., D.S., M.D.F., M.M., G.S.).
Alexander Y IngLaboratory of Molecular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (A.Y.I., B.F.).
Robert NussbaumInvitae, Inc, San Francisco, CA (J.G., R.N.).
Birgit FunkeLaboratory of Molecular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (A.Y.I., B.F.).
Matthew T WheelerDivision of Cardiovascular Medicine, Department of Medicine (V.N.P., C.C., C.R., M.T.W., E.A.A.), Stanford University School of Medicine, CA.
Ray E HershbergerDivision of Human Genetics, Department of Medicine (R.E.H.), The Ohio State University College of Medicine, Columbus.
Stuart CookNational Heart Lung Institute, Imperial College London, UK and National Heart Centre, Singapore (S.C.).
Lars M SteinmetzDepartment of Genetics (L.M.S., B.M., E.A.A.), Stanford University School of Medicine, CA.
Neal K LakdawalaBrigham and Women's Hospital, Partners Health Care and Harvard Medical School, Boston, MA (S.K., N.K.L.).
Matthew R G TaylorCardiovascular Institute, University of Colorado Anschutz Medical Campus, Aurora (S.G., M.R.G.T., L.M.).
Luisa MestroniCardiovascular Institute, University of Colorado Anschutz Medical Campus, Aurora (S.G., M.R.G.T., L.M.).
Marco MerloCardiovascular Department, Azienda Sanitaria Universitaria Integrata, University of Trieste, Italy (M.G., D.S., M.D.F., M.M., G.S.).
Gianfranco SinagraCardiovascular Department, Azienda Sanitaria Universitaria Integrata, University of Trieste, Italy (M.G., D.S., M.D.F., M.M., G.S.).
Christopher SemsarianDepartment of Cardiology, Royal Prince Alfred Hospital and Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, University of Sydney, New South Wales, Australia (J.I., C.S.).
Benjamin MederDepartment of Genetics (L.M.S., B.M., E.A.A.), Stanford University School of Medicine, CA.
Daniel P JudgeDepartment of Medicine, Medical University of South Carolina, Charleston (D.P.J.).
Euan AshleyDivision of Cardiovascular Medicine, Department of Medicine (V.N.P., C.C., C.R., M.T.W., E.A.A.), Stanford University School of Medicine, CA.
Stanford University · USAzienda Sanitaria Universitaria Integrata di Trieste · ITBrigham and Women's Hospital · USUniversity of Colorado Anschutz Medical Campus · USHeidelberg University · DEInvitae (United States) · USRoyal Prince Alfred Hospital · AUGenomic Health (United States) · USJohns Hopkins University · USLung Institute · USMedical University of South Carolina · USThe Ohio State University · US

Funding

WHOLE YEAST GENOME TRANSCRIPTIONAL AND FUNCTIONAL GENE MAPS--A FEASIBILITY STUDYP01HG000205 · NHGRI · STANFORD UNIVERSITY · PI HOWE, ROGER THOMAS, JI, HANLEE P · 1990 to 2016
$120.9M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Integrative genomics of human heart failureR01HL105993 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI ASHLEY, EUAN A, CAPPOLA, THOMAS P. · 2011 to 2014
$8.9M
Molecular Epidemiology of Dilated CardiomyopathR01HL069071 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MESTRONI, LUISA · 2002 to 2005
$2.3M
Cardiomyocyte phenotype and mechanotransduction in Filamin C gene variants causing arrhythmogenic cardiomyopathyR01HL147064 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MESTRONI, LUISA, TAYLOR, MATTHEW R · 2020 to 2023
$2.1M
Mitochondrial to nuclear gene transfer via synthetic evolutionR01GM111873 · NIGMS · STANFORD UNIVERSITY · PI STEINMETZ, LARS M · 2015 to 2018
$1.3M
An Essential Role for miR-29b in the Protective Effect of Apelin in Diabetic Vascular StiffnessF32HL134233 · NHLBI · STANFORD UNIVERSITY · PI PARIKH, VICTORIA · 2016 to 2018
$107k
NCATS NIH HHS UL1 TR001082NHGRI NIH HHS P01 HG000205NHLBI NIH HHS F32 HL134233NHLBI NIH HHS R01 HL069071NHLBI NIH HHS R01 HL105993NHLBI NIH HHS R01 HL147064NIGMS NIH HHS R01 GM111873
6 · The paper itself

Abstract

Background Variants in the cardiomyocyte-specific RNA splicing factor RBM20 have been linked to familial cardiomyopathy, but the causative genetic architecture and clinical consequences of this disease are incompletely defined. Methods and Results To define the genetic architecture of RBM20 cardiomyopathy, we first established a database of RBM20 variants associated with cardiomyopathy and compared these to variants observed in the general population with respect to their location in the RBM20 coding transcript. We identified 2 regions significantly enriched for cardiomyopathy-associated variants in exons 9 and 11. We then assembled a registry of 74 patients with RBM20 variants from 8 institutions across the world (44 index cases and 30 from cascade testing). This RBM20 patient registry revealed highly prevalent family history of sudden cardiac death (51%) and cardiomyopathy (72%) among index cases and a high prevalence of composite arrhythmias (including atrial fibrillation, nonsustained ventricular tachycardia, implantable cardiac defibrillator discharge, and sudden cardiac arrest, 43%). Patients harboring variants in cardiomyopathy-enriched regions identified by our variant database analysis were enriched for these findings. Further, these characteristics were more prevalent in the RBM20 registry than in large cohorts of patients with dilated cardiomyopathy and TTNtv cardiomyopathy and not significantly different from a cohort of patients with LMNA-associated cardiomyopathy. Conclusions Our data establish RBM20 cardiomyopathy as a highly penetrant and arrhythmogenic cardiomyopathy. These findings underline the importance of arrhythmia surveillance and family screening in this disease and represent the first step in defining the genetic architecture of RBM20 disease causality on a population level.

Indexed as

Arrhythmias, CardiacCardiomyopathiesDeath, Sudden, CardiacHumansMutationRegistriesRNA-Binding Proteinsribonucleic acid binding motif protein 20, humanRNA-Binding Proteinsarrhythmias, cardiaccardiomyopathiesgeneticsRNA splicing

Identifiers

PMID30871351
PMCPMC6422044
OpenAlexW2921063092

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.